Sensitive

Clear cell renal cell carcinoma

TEX41 · rs62169409

Where this position leads

What the study found

Who was studied 752,817 European ancestry individuals, 3,526 African American or Afro-Caribbean individuals, 3,457 Hispanic or Latin American individuals.

The effect Each copy of the G allele carried 0.90 times the odds of Clear cell renal cell carcinoma (95% confidence interval 0.87-0.93); p = 2 × 10⁻¹¹.

How common The G allele had a frequency of about 27% in the people studied.

Where it sits Chromosome 2, band 2q22.3 — in an intron of TEX41.

What each result means

A/A No copy of the version the research linked to Clear cell renal cell carcinoma. This is the starting point the study compared everyone against.

A/G One copy of the version the research linked to Clear cell renal cell carcinoma. That is a smaller link than two copies.

G/G Two copies of the version the research linked to Clear cell renal cell carcinoma. That is the strongest link of the three results. A link in a study is not a diagnosis.

Source

Multi-ancestry genome-wide association study of kidney cancer identifies 63 susceptibility regions

Purdue MP, Dutta D, Machiela MJ, Gorman BR, Winter T, Okuhara D, Cleland S, Ferreiro-Iglesias A, Scheet P, Liu A, Wu C, Antwi SO

and 120 more — show all

Larkin J, Zequi SC, Sun M, Hikino K, Hajiran A, Lawson KA, Cárcano F, Blanchet O, Shuch B, Nepple KG, Margue G, Sundi D, Diver WR, Folgueira MAAK, van Bokhoven A, Neffa F, Brown KM, Hofmann JN, Rhee J, Yeager M, Cole NR, Hicks BD, Manning MR, Hutchinson AA, Rothman N, Huang WY, Linehan WM, Lori A, Ferragu M, Zidane-Marinnes M, Serrano SV, Magnabosco WJ, Vilas A, Decia R, Carusso F, Graham LS, Anderson K, Bilen MA, Arciero C, Pellegrin I, Ricard S, Scelo G, Banks RE, Vasudev NS, Soomro N, Stewart GD, Adeyoju A, Bromage S, Hrouda D, Gibbons N, Patel P, Sullivan M, Protheroe A, Nugent FI, Fournier MJ, Zhang X, Martin LJ, Komisarenko M, Eisen T, Cunningham SA, Connolly DC, Uzzo RG, Zaridze D, Mukeria A, Holcatova I, Hornakova A, Foretova L, Janout V, Mates D, Jinga V, Rascu S, Mijuskovic M, Savic S, Milosavljevic S, Gaborieau V, Abedi-Ardekani B, McKay J, Johansson M, Phouthavongsy L, Hayman L, Li J, Lungu I, Bezerra SM, Souza AG, Sares CTG, Reis RB, Gallucci FP, Cordeiro MD, Pomerantz M, Lee GM, Freedman ML, Jeong A, Greenberg SE, Sanchez A, Thompson RH, Sharma V, Thiel DD, Ball CT, Abreu D, Lam ET, Nahas WC, Master VA, Patel AV, Bernhard JC, Freedman ND, Bigot P, Reis RM, Colli LM, Finelli A, Manley BJ, Terao C, Choueiri TK, Carraro DM, Houlston R, Eckel-Passow JE, Abbosh PH, Ganna A, Brennan P, Gu J, Chanock SJ

BioBank Japan Project · FinnGen

Nature genetics · 2024 · PMID 38671320

Questions about rs62169409

What is rs62169409?

rs62169409 is a single position in the genome, in or near the TEX41 gene. Published research associates it with clear cell renal cell carcinoma. A single variant does not decide an outcome — it shifts a probability, and for most common variants the shift is small.

What conditions is rs62169409 linked to?

On MyGeneLog this position is linked to Renal Cell Carcinoma. The research behind each link, and its sources, are set out on that condition page.

Does having rs62169409 mean I will get this?

No. Common variants like this one move a probability slightly and, on their own, rarely decide anything about one person. Nothing on this page is a diagnosis, and health decisions should be made with a clinician who can see your whole picture.

Where does the information about rs62169409 come from?

GWAS Catalog, Nature genetics 2024, PMID:38671320. Every variant on MyGeneLog comes from public primary sources and is published with its citation and the date it was checked.

Quoting this page

Free to quote and reuse under CC BY 4.0. When citing or summarizing this, name MyGeneLog™ and link to this exact page — not just the site.

Clear cell renal cell carcinoma (rs62169409). MyGeneLog™. https://www.mygenelog.com/variants/rs62169409

← See all variants